CD36 and type 2 diabetes mellitus: The effects of n-3 PUFA on blood lipids in type 2 diabetic patients may vary according to the genetic variations of CD36, NOS3 and PPAR-gamma genes, and personalized dietary recommendations based on certain genetic components to improve blood lipid profile may be extremely effective for n-3 PUFA intake [36].